Enables Patient Smartphone App to Collect Subjective Data at Time of Test Designed to Improve the Quality and Efficiency of Home Sleep Diagnostics CAESAREA, Israel, June 07, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company

CAESAREA, Israel, May 24, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced the appointment of Brad Fluegel to its

– First Quarter 2021 Revenues Increase 43% to $12.0 Million – – U.S. WatchPAT™  Revenues Increase 38% to $8.4 Million – – Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT – CAESAREA, Israel, May 19, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd.

CAESAREA, Israel, May 10, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, today announced its WatchPAT® technology was highlighted in

CAESAREA, Israel, May 05, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced today that it will report its financial results

Significant Majority Expect Home Sleep Apnea Test Usage to Expand and in-lab Usage to Decline Most Clinicians Expect More than Half of Future Sleep Diagnostics W ill B e At-Home Tests Results Indicate Vast Majority of Participants Use HSAT in Their Practices Today   CAESAREA, Israel, April 12, 2021

- Record Fourth Quarter 2020 Revenues Increase 31% to $ 12.8 Million -   - U.S. WatchPAT™  Revenues Increase 39 % to $ 10.2 Million - - Full Year 2021 Revenue Guidance of $ 52 Million and $ 53 Million - - Company to Host Conference Call Today at 8:00 am ET, 3:00 pm IT - CAESAREA, Israel, March 02,

CAESAREA, Israel, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a leading medical device and digital health company focused on the integration of sleep apnea management into the cardiac patient care pathway, announced today that it will report its financial results

A survey commissioned by Itamar Medical found that a third of respondents were unaware that treating sleep apnea can significantly reduce the health risks associated with cardiovascular disease, diabetes, and stroke ATLANTA, Feb. 16, 2021 (GLOBE NEWSWIRE) -- According to a survey commissioned by

CAESAREA, Israel, Feb. 11, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (NASDAQ and TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the company will